We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Shock Wave Device Helps Treat Diabetic Foot Ulcers

By HospiMedica International staff writers
Posted on 10 Jan 2018
Print article
Image: An extracorporeal shock wave system treats DFUs (Photo courtesy of Sanuwave).
Image: An extracorporeal shock wave system treats DFUs (Photo courtesy of Sanuwave).
A novel extracorporeal shock wave system uses pulses of energy in the shock wave spectrum to mechanically stimulate the diabetic foot ulcer (DFU).

The Sanuwave (Suwanee, GA, USA) Dermapace System is based on pulsed acoustic cellular expression (PACE) technology, which utilizes high-energy acoustic pressure waves to produce compressive and tensile stresses on cells and tissue structures in order to elicit a series of biological responses that increase tissue perfusion and arteriogenesis, disrupt biofilm, initiate pro-inflammatory responses, invoke cytokine and chemokine effects, growth factor upregulation, and angiogenesis. The result is a regeneration of tissues such as skin, musculoskeletal, and vascular structures.

The system is intended for the treatment of chronic, full-thickness DFUs with wound areas measuring no larger than 16 cm2, which extend through the epidermis, dermis, tendon, or capsule, but without bone exposure. During treatment, the dermaPACE device pulse applicator is gently applied to the wound surface; an audible “popping” sound is generated until treatment end. In general, only a few treatments lasting just a few minutes are needed; however, treatment time, as well as the overall number of treatments, depends on the wound condition.

“Not all wounds, nor all patients are the same; therefore, each wound is treated on an individual basis, based on the treating physician’s knowledge and the treatment options available. Due to its non-invasive nature, the dermaPACE System does not prevent the use of other treatment options,” said Kevin Richardson II, CEO and chairman of the Board of Sanuwave. “The dermaPACE system offers the ability to manage the DFUs chronicity, and is a powerful tool in the clinician’s arsenal to achieve wound closure.”

Diabetes patients often suffer from nerve and circulation problems in the feet, which reduce their perception of pain. The nerve pathways that ensure that weight is automatically transferred from one foot to the other during prolonged standing are disrupted, and as a result, diabetics do not notice that their toes, heels, or the balls of their feet are too heavily loaded. The foot receives no relief, and due to the neuropathy, pressure sores, DFUs, and infections may go unnoticed. Serious cases may even lead to amputation.

Related Links:
Sanuwave

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Vital Signs Monitor
Aurus 10

Print article

Channels

Surgical Techniques

view channel
Image: LUMISIGHT and Lumicell DVS offer 84% diagnostic accuracy in detecting residual cancer (Photo courtesy of Lumicell)

Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery

Breast cancer is becoming increasingly common, with statistics indicating that 1 in 8 women will develop the disease in their lifetime. Lumpectomy remains the predominant surgical intervention for treating... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.